Fundz

Natera Launches Prospera™ Kidney With Quantification To Further Improve Test Performance, Demonstrating Commitment To Innovation In Transplantation

PUBLIC · NTRASep 09, 2021

Round Type

Funding Round

AustinBiotechnologyHealth CareGeneticsHealth Diagnostics

Description

Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, today announced the launch of Prospera with Quantification, the only cfDNA test for kidney rejection that provides three values — the quantity of donor-derived cfDNA (dd-cfDNA), fraction of dd-cfDNA and total cfDNA on every report. Combining these three metrics has been shown to improve sensitivity when evaluating transplant rejection, compared to using dd-cfDNA fraction alone. Currently, other commercially available cfDNA tests that assess transplant rejection only report the fraction of dd-cfDNA.

Quick answer

Natera raised an undisclosed amount in a Funding Round round, dated September 9, 2021. Natera is based in Austin, Texas, United States.

How much did Natera raise?
Natera raised an undisclosed amount in a Funding Round round on September 9, 2021.
What does Natera do?
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health.
Where is Natera based and how big is it?
Natera is based in Austin, Texas, United States. Fundz records about 4,500 employees.
Who are the decision-makers at Natera?
Fundz holds 2 contacts at Natera, including the Vice President. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Genetics and Health Diagnostics around the same time

Companies in the same sectors as Natera that raised within 45 days of this round, from Fundz verified event records.

  • WaveFront Dynamics Inc. raised $700K (Seed) on October 14, 2021.
  • Quantum Cyber N.V. raised $603K (Seed) on September 8, 2021.
  • Oxford Cancer Analytics raised $1.7M (Seed) on September 6, 2021.
  • Kate Therapeutics raised $35M on August 31, 2021.
  • Prolocor Inc. raised $723K (Seed) on August 25, 2021.
  • Blackford Analysis raised $687K (Seed) on August 20, 2021.

Who to call at Natera, and when

A new round usually means Natera is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Natera raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Natera, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Natera. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Natera

Location

13011 Mccallen Pass

Austin, Texas, United States

About

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment. Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Natera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMatt L., Vice President hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Natera's next move

See what Strategic adds

Natera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.